Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219004 · ClinicalTrials.gov registry record · NA
Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.
A NA study of Diabetic Foot Ulcer (DFU) and Lower Extremity Chronic Ulcers in Diabetics, sponsored by Tides Medical.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 5
- Study locations
NCT07219004: Completed NA study of Diabetic Foot Ulcer (DFU) and Lower Extremity Chronic Ulcers in Diabetics, sponsored by Tides Medical.
NCT07219004 is a NA study of Diabetic Foot Ulcer (DFU) and Lower Extremity Chronic Ulcers in Diabetics that has completed, run by Tides Medical. The registered enrollment target is 30 participants, below the 516-participant average among 13 other Diabetic Foot Ulcer (DFU) trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07219004, a NA study of Diabetic Foot Ulcer (DFU) and Lower Extremity Chronic Ulcers in Diabetics, has completed, sponsored by Tides Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is study is to determine if A tri-layered dehydrated human amnion/chorion/amnion composite graft would help non-healing lower extremity diabetic ulcers to heal over a 12 week time period.
Primary Outcome
complete wound closure measured by 100% epithelialization
Conditions Studied
Interventions
- OTHER amniotic membrane
Study Locations (5)
Texas
- The Serena Group Austin Research Center - Austin
- El Campo Memorial Advanced Wound Care Clinic - El Campo
Florida
- Three Rivers Wound and Hyperbaric Center - North Port
New York
- Serena Group Reseach Center - Buffalo
Pennsylvania
- Serena Group - Monroeville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-03-03 |
| Est. Completion | 2023-09-27 |
| Phase | NA |
What the finished NCT07219004 record still lists
NCT07219004 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 516-participant average among 13 other Diabetic Foot Ulcer (DFU) trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Diabetic Foot Ulcer (DFU) appearing as the primary indexed condition, and to 1 intervention - of which amniotic membrane is the first listed.
NCT07219004 lists 5 locations in 4 states (Texas, Florida, New York).
Frequently Asked Questions
What is clinical trial NCT07219004 about?
NCT07219004 is a clinical study titled "Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.". This is study is to determine if A tri-layered dehydrated human amnion/chorion/amnion composite graft would help non-healing lower extremity diabetic ulcers to heal over a 12 week time period.
What is the current status of trial NCT07219004?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-03-03. Estimated completion is 2023-09-27.
What conditions does trial NCT07219004 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer (DFU), Lower Extremity Chronic Ulcers in Diabetics.
What interventions are being tested in trial NCT07219004?
The interventions under investigation include: amniotic membrane (OTHER).
Who is sponsoring clinical trial NCT07219004?
This trial is sponsored by Tides Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219004 being conducted?
This trial has 5 study locations across Florida, New York, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer (DFU)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07219004's enrollment target sits among peer trials
30 13th of 13 higher than 1 of 13 other Diabetic Foot Ulcer (DFU) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer (DFU) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
RECRUITING · NA
-
CARE-D-FOOT-Nav Pilot
RECRUITING · NA
-
A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs
RECRUITING · NA
-
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations
RECRUITING · NA
-
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
RECRUITING · NA
-
Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI